No. of Pages: 142 | Report Code: TIPRE00022080 | Category: Life Sciences
Las alergias son respuestas hipersensibles del sistema inmunológico humano a la sustancia que entra en contacto con el cuerpo. Las alergias graves pueden poner en peligro la vida y alterar el funcionamiento normal de los órganos, como el asma, que provoca un mal funcionamiento de los pulmones. El tratamiento más eficaz para la alergia es evitar los alérgenos conocidos, aunque existen medicamentos como esteroides y antihistamínicos y otras terapias que previenen las alergias.
< /p>
Se espera que el mercado de tratamiento de alergias de Asia Pacífico alcance los 9.991,64 millones de dólares estadounidenses en 2028 de US$ 5.662,06 millones en 2020; se estima que crecerá con una tasa compuesta anual del 7,4% de 2021 a 2028. El crecimiento del mercado se atribuye a la creciente adopción de la inmunoterapia en el tratamiento de las alergias y a la evolución de los tratamientos para las alergias alimentarias. Sin embargo, la falta de conciencia sobre los tratamientos para las alergias es un factor clave que frena el crecimiento del mercado.
El mercado de tratamiento de alergias de Asia Pacífico, según el tipo de alergia, se segmentó en alergia ocular, rinitis, asma, alergia cutánea, alergias alimentarias, y otras alergias. En 2020, el segmento de la rinitis ocupó la mayor parte del mercado, mientras que se espera que el segmento de alergias alimentarias crezca al ritmo más rápido durante los próximos años.
El mercado de tratamiento de alergias de Asia Pacífico, basado en el tratamiento, se segmentó en medicamentos antialérgicos e inmunoterapia. En 2020, el segmento de medicamentos antialérgicos ocupó la mayor cuota de mercado. Sin embargo, se espera que la inmunoterapia crezca al ritmo más rápido durante los próximos años.
Algunas de las fuentes primarias y secundarias asociadas con este informe en El mercado de tratamiento de alergias de Asia Pacífico es el Colegio Indio de Alergia, Asma e Inmunología Aplicada (ICAAI), la Sociedad Australiana de Inmunología Clínica y Alergia (ASCIA) y el Instituto Nacional de Alergias y Enfermedades Infecciosas (NIAID).
• China
• Japón
• India
• Australia
• Corea del Sur
• Resto de Asia Pacífico
• Johnson and Johnson Services, Inc.
• Sanofi
• AbbVie\'s Inc.
• ALK-Abelló; A/S
• Terapéutica de alergias
• Stallergenes Greer
Strategic insights for Asia Pacific Allergy Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 5,662.06 Million |
| Market Size by 2028 | US$ 9,991.64 Million |
| Global CAGR (2021 - 2028) | 7.4% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By Tipo de alergia
|
| Regions and Countries Covered | Asia-Pacífico
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Allergy Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Asia Pacific Allergy Treatment Market
The Asia Pacific Allergy Treatment Market is valued at US$ 5,662.06 Million in 2020, it is projected to reach US$ 9,991.64 Million by 2028.
As per our report Asia Pacific Allergy Treatment Market, the market size is valued at US$ 5,662.06 Million in 2020, projecting it to reach US$ 9,991.64 Million by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.
The Asia Pacific Allergy Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Allergy Treatment Market report:
The Asia Pacific Allergy Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Allergy Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Allergy Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Allergy Treatment Market
